http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111675661-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate | 2020-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111675661-B |
titleOfInvention | A kind of diarylpyrimidine HIV-1 reverse transcriptase inhibitor containing trans double bond and preparation method and application thereof |
abstract | The invention relates to a diarylpyrimidine HIV-1 reverse transcriptase inhibitor containing a trans double bond, and a preparation method and application thereof. The compound has the structure shown in formula I. The present invention also relates to pharmaceutical compositions containing compounds of formula I. The present invention also provides the use of the above-mentioned compounds and compositions containing one or more of such compounds in the manufacture of medicaments for the treatment and prevention of human immunodeficiency virus (HIV). |
priorityDate | 2020-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 190.